<DOC>
	<DOC>NCT02790528</DOC>
	<brief_summary>The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.</brief_summary>
	<brief_title>Statin Therapy In Patients With Vasospastic Angina</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina Pectoris, Variant</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Age 19 and more Vasospastic angina LDL less than 160mg/dl Written consent Coronary artery stenosis more than 50% or ischemic coronary disease History of percutaneous coronary intervention Cerebrovascular diseases or peripheral Dyslipidemia required statin therapy Heart failure, arrhythmogenic right ventricular dysplasia, hypertrophic cardiomyopathy, akinesia or aneurysm on left ventricular wall, anomaly of coronary artery NYHA III and IV Arrhythmia Primary cardiac electrical diseases Cardiac pacemaker or implantable defibrillator Pregnancy or breast feeding Life expectancy less than 2 years</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>statin</keyword>
	<keyword>vasospastic angina</keyword>
</DOC>